• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Dihydroartemisinin

Dihydroartemisinin

Product ID A6979
Cas No. 71939-50-9
Purity ≥96%
Product Unit SizeCostQuantityStock
50 mg $50.90 In stock
100 mg $81.70 In stock
500 mg $132.60 In stock
1 g $193.90 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Dihydroartemisinin is a sesquiterpene lactone that can be derived from Artemisia. Dihydroartemisinin exhibits anticancer, antiviral, anti-inflammatory, anti-asthma, and anti-parasitic activities. Artemisinins such as dihydroartemisinin are best known for their antimalarial activity. Dihydroartemisinin induces apoptosis in colorectal cancer cells, increasing levels of ROS and Bax; it also inhibits mTORC1 in rhabdomyosarcoma cells. Dihydroartemisinin displays antimicrobial activity against Plasmodium, Schistosoma, and human cytomegalovirus. This compound also decreases levels of inflammatory cells, Th2 cytokines, IgE, and mucus secretion, suppressing airway hyper-responsiveness in animal models of asthma.

Product Info

Cas No.

71939-50-9

Purity

≥96%

Formula

C15H24O5

Formula Wt.

284.35

IUPAC Name

(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol

Synonym

Dihydroartemisinine, Dihydroqinghaosu, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10- ol

Melting Point

140°C

Solubility

Insoluble in water. Soluble in acetone and ethanol.

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

A6979 MSDS PDF

Info Sheet

A6979 Info Sheet PDF

References

Ontikatze T, Rudner J, Handrick R, et al. Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells. Front Oncol. 2014 May 19;4:116. PMID: 24904829.

Wanzira H, Kakuru A, Arinaitwe E, et al. Longitudinal Outcomes in a Cohort of Ugandan Children Randomized to Artemether-lumefantrine Versus Dihydroartemisinin-piperaquine for the Treatment of Malaria. Clin Infect Dis. 2014 May 13. [Epub ahead of print]. PMID: 24825870.

Li HJ, Xu FL, Wang YH, et al. Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection. Parasitol Res. 2014 Jan;113(1):239-41. PMID: 24146209.

Flobinus A, Taudon N, Desbordes M, et al. Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives. J Antimicrob Chemother. 2014 Jan;69(1):34-40. PMID: 24003183.

Odaka Y, Xu B, Luo Y, et al. Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells. Carcinogenesis. 2014 Jan;35(1):192-200. PMID: 23929438.

Wei M, Xie X, Chu X, et al. Dihydroartemisinin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model. Immunopharmacol Immunotoxicol. 2013 Jun;35(3):382-9. PMID: 23635079.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • I9060

    IWP-2

    PORCN inhibitor.

    ≥98%
  • P2818

    Phentolamine Methanesulfonate

    ATP-sensitive K+ channel activator, α-adrenerg...

    ≥98%
  • R3221

    3-Formylrifamycin

    Rifamycin derivative, induces pore formation in...

    ≥98%
  • O456505

    Olmutinib

    EGFR inhibitor.

    ≥98%
  • P6858

    Procarbazine Hydrochloride

    Hydrazine derivative, DNA alkylator; MAO inhibi...

    ≥97%
  • C7097

    Cryptotanshinone

    Quinoid diterpene found in species of Salvia; S...

    ≥90%
  • C4646

    Clofarabine

    Nucleoside (adenosine) analog; DNA chain termin...

    ≥98%
  • B5648

    Bombesin

    GRP analog, found in Bombina; bombesin and GRP ...

    ≥95%
  • T7032

    Triamcinolone

    Synthetic steroid; glucocorticoid agonist.

    ≥98%
  • V182705

    Verubecestat

    BACE1 inhibitor

    ≥98%
  • S0044

    Salbutamol Free Base

    β2-adrenergic agonist.

    ≥98%
  • L1852

    Lenalidomide

    Thalidomide derivative; cereblon and TNF-α inh...

    ≥98%
  • T1605

    Tebuconazole

    Triazole; 14-α demethylase inhibitor, voltage-...

    ≥98%
  • F8272

    Fusarenon X

    Trichothecene mycotoxin produced by Fusarium.

    ≥98%
  • S824766

    Sutezolid

    Bactericidal.

    ≥98%
  • V174459

    Velpatasvir

    Inhibits NS5A

    ≥99%
  • O610292

    Ophiobolin B

    Naturally occurring sesteterpenoid.

    ≥98%
  • N7332

    NSI-189

    Stem cell neurogenesis inducer.

    ≥99%
  • E6257

    Epothilone B

    Microtubule depolymerization inhibitor.

    ≥98%
  • C9613

    Cyclosporin D

    Cyclosporin metabolite; weak calmodulin inhibit...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only